Andrew Nicholas Carr is an accomplished inventor based in Maineville, OH (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative dosage forms. With a total of 2 patents to his name, Carr's work focuses on enhancing the effectiveness and convenience of pain relief medications.

Latest Patents

Carr's latest patents include an innovative extended relief dosage form. This dosage form features a first portion that can be an immediate release portion, which may include a pain reliever such as naproxen or naproxen sodium. The second portion is designed for extended release and can comprise pseudoephedrine or a pharmaceutically acceptable salt thereof, and/or dextromethorphan or a pharmaceutically acceptable salt thereof. Additionally, the dosage form can optionally include a stabilizing agent. This innovative design is adapted to maintain a therapeutically effective amount of the pain reliever, pseudoephedrine, or dextromethorphan for at least eight hours.

Career Highlights

Carr is currently associated with The Procter & Gamble Company, where he continues to innovate in the pharmaceutical sector. His work is characterized by a commitment to improving patient outcomes through effective medication delivery systems.

Collaborations

Throughout his career, Carr has collaborated with notable colleagues, including Mark Edward Stella and John Richard Entwisle. These partnerships have contributed to the advancement of his innovative projects and patents.

Conclusion

Andrew Nicholas Carr exemplifies the spirit of innovation in the pharmaceutical industry. His contributions, particularly in the development of extended relief dosage forms, highlight his dedication to improving healthcare solutions. His work continues to impact the field positively, making him a noteworthy inventor in today's landscape.

This text is generated by artificial intelligence and may not be accurate.